July 23, 2012 — The IT and medical technology company Sectra has acquired the product rights for Intulo, a system that monitors radiation doses, from the Swedish medical IT company Krucom AB. The system enables major time and quality gains in medical care and reduces the risk of patients being exposed to unnecessarily high radiation doses in conjunction with radiology examinations.

 

July 23, 2012 — Siemens Healthcare expands its ultrasound portfolio with the portable Acuson P300 ultrasound system designed for a wide variety of clinical settings. Integrating high-performance hardware and software, the Acuson P300 system offers 13 multifrequency transducers for high clinical versatility. The system also features advanced image optimization technologies to support both routine and specialty application needs.

July 23, 2012 — Medtronic Inc. announced the first patient enrollment in a clinical trial comparing the CoreValve system with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk to undergo open heart surgery. The Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial will evaluate the potential for the minimally invasive system to be considered for less-sick patients who typically are treated with open-heart surgical aortic valve replacement (SAVR) today.

July 20, 2012 — Ticagrelor, a blood-thinning drug approved by the U.S. Food and Drug Administration (FDA) in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according to joint updated guidelines issued by the American Heart Association (AHA) Task Force on Practice Guidelines and the American College of Cardiology (ACCF) Foundation.

July 20, 2012 — The online clinical drug resource Drugs.com released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers.

July 20, 2012 — The ability to see inside the arteries of vascular disease patients in high resolution before and during stenting procedures can offer valuable information. A new study of optical coherence tomography (OCT) in the Journal of Endovascular Therapy confirms the safety and feasibility of this imaging technique in the carotid arteries.

July 20, 2012 — Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior vena cava filter (VCF) with bi-directional retrieval.

July 20, 2012 —Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier for its lead product candidate, Imagify (perflubutane polymer microspheres) for injectable suspension, and is now starting the process of filing the MAA dossier with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now